About Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
"Białostockie Centrum Onkologii im. Marii Skłodowskiej-Curie w Białymstoku jest jedyną w województwie podlaskim wielospecjalistyczną placówką zajmującą się rozpoznawaniem i leczeniem chorób nowotworowych. Białostockie Centrum Onkologii ma długą historię z początkami przy Szpitalu Ginekologiczno-Położniczym. Od 1993 r. ma patrona - Marię Skłodowską-Curie."
Clinical Trials at Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
During the past decade, Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
According to Clinical.Site data, the most researched conditions in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej" are
"Breast Cancer" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej" in a lesser frequency.
Clinical Trials Intervention Types at Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
Most popular intervention types in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (2 trials), "Pertuzumab" (2 trials), "Placebo" (2 trials), "Trastuzumab" (2 trials) and "Capecitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
The vast majority of trials in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej" are
2 trials for "All" genders.
Clinical Trials Status at Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej
Currently, there are NaN active trials in "Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Bialostockie Ctr Onkologii; Oddzial Chemioterapii Dziennej, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".